First results from BladderPath: A randomised trial of MRI versus cystoscopic staging for newly diagnosed bladder cancer
NOVEL THERAPIES FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER.
COMPARISON OF ROBOT-ASSISTED AND OPEN RADICAL CYSTECTOMY IN RECOVERY OF PATIENT-REPORTED AND PERFORMANCE-RELATED MEASURES OF INDEPENDENCEA SECONDARY ANALYSIS OF A RANDOMIZED CLINICAL TRIAL
Welcome & Introduction
Decoding Treatment Options for EGFRm NSCLC
Osimertinib as Adjuvant Therapy in patients with resected EGFRm Stage IB IIIA NSCLC-Updated Results from ADAURA
Welcome & Introduction
Cancer Awareness, Screening & Early diagnosis. Where are we now and what are the solutions- India Centric?
Panel Discussion - Access to cancer treatment. Current milestones & way forward for cancer care for all, in India.
Welcome & Introduction
Role of Alecensa in 1L ALK+ NSCLC patients Beyond The Barriers
Lorlatinib as a first line option for ALK positive metastatic NSCLC